GlobalData on MSN
FDA accepts Otsuka’s centanafadine application for ADHD treatment
The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.
With an expiration date still more than a year away, here's what the latest details reveal.
The FDA has accepted Otsuka’s New Drug Application for centanafadine, a first-in-class norepinephrine, dopamine and serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit ...
MedPage Today on MSN
Next DSM insights; FDA reviewing non-stimulant ADHD drug; 10M people microdosing
News and commentary from the psychiatry world ...
It has long been assumed that psychostimulants help those with ADHD by acting on the brain’s attention circuitry. However, ...
From 2022 to 2024, stimulant prescriptions issued in Connecticut increased by 13.2 percent, according to data from the state.
Scientists are updating their view of how drugs like Adderall and Ritalin help children with attention deficit hyperactivity disorder stay on task. The latest evidence is a study of thousands of brain ...
Scientists are changing their view of how drugs like Adderall and Ritalin help children with ADHD stay on task. NPR's Jon Hamilton reports on a new study that found the drugs act on brain networks ...
Add Yahoo as a preferred source to see more of our stories on Google. Robert F. Kennedy Jr. speaks after being sworn in as secretary of Health and Human Services in the Oval Office at the White House ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results